Abstract
Summary
Middle East & Africa AI in Bioinformatics Market is projected to register a substantial CAGR of 31.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation:
Middle East and Africa AI in Bioinformatics Market, By Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors), Country (the Middle East and Africa). This region is further segmented into major countries such as Saudi Arabia, UAE, Israel, Egypt, South Africa, and Rest of the Middle East and Africa. Industry Trends and Forecast to 2029.
Driver/Opportunity
• Due to the rise in healthcare expenditure and strategic initiatives taken by key market players
Market Players:
Some of the key market players for the Middle East and Africa AI in bioinformatics market are listed below:
• JADBio & Gnosis Data Analysis
• SOPHiA GENETICS
• Biomax Informatics AG
• DNASTAR
• Ardigen
• QIAGEN
• Source BioScience
• NeoGenomics Laboratories
• Eurofins Scientific
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• CelbridgeScience
• Dassault Systemes
• Fios Genomics
• Insilico Medicine
• Strand Life Sciences
• Paige AI, Inc.
• SomaLogic Operating Co., Inc.
• iNDX. Ai.
• Elucidata
Table of Contents
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW OF MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 OFFERING LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 MARKET SECTOR COVERAGE GRID 41
2.11 VENDOR SHARE ANALYSIS 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTER’S FIVE FORCES 49
5 MARKET OVERVIEW 50
5.1 DRIVERS 52
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 52
5.1.2 GROWING DEMAND FOR BIOINFORMATICS 53
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 53
5.2 RESTRAINTS 54
5.2.1 HIGH COST OF INSTRUMENTATION 54
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 54
5.3 OPPORTUNITIES 55
5.3.1 RISE IN HEALTHCARE EXPENDITURE 55
5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 55
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 56
5.4 CHALLENGES 56
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 56
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 57
6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING 58
6.1 OVERVIEW 59
6.2 SERVICES 62
6.3 SOFTWARE 62
6.4 OTHERS 63
7 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE 65
7.1 OVERVIEW 66
7.2 MACHINE LEARNING 69
7.3 DEEP LEARNING 69
7.4 OTHERS 70
8 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 72
8.1 OVERVIEW 73
8.2 BIOINFORMATICS SERVICES 76
8.2.1 DATA ANALYSIS 77
8.2.2 SEQUENCING SERVICES 77
8.2.3 DATABASE MANAGEMENT 77
8.2.4 OTHERS 77
8.3 BIOINFORMATICS PLATFORMS 77
8.3.1 SEQUENCE ANALYSIS PLATFORMS 78
8.3.2 SEQUENCE ALIGNMENT PLATFORMS 78
8.3.3 STRUCTURAL ANALYSIS PLATFORMS 79
8.3.4 SEQUENCE MANIPULATION PLATFORMS 79
8.3.5 OTHERS 79
8.4 KNOWLEDGE MANAGEMENT TOOLS 79
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 80
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 80
9 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION 81
9.1 OVERVIEW 82
9.2 GENOMICS 85
9.3 CHEMOINFORMATICS & DRUG DESIGN 85
9.4 PROTEOMICS 86
9.5 DNA SEQUENCING 87
9.6 SYSTEM BIOLOGY 88
9.7 TRANSCRIPTOMICS 89
9.8 TEXT MINING 90
9.9 MICROARRAYS 91
9.10 METABOLOMICS 92
9.11 OTHERS 93
10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR 94
10.1 OVERVIEW 95
10.2 MEDICAL BIOTECHNOLOGY 98
10.3 ANIMAL BIOTECHNOLOGY 98
10.4 PLANT BIOTECHNOLOGY 99
10.5 ENVIRONMENTAL BIOTECHNOLOGY 100
10.6 FORENSIC BIOTECHNOLOGY 101
10.7 OTHERS 102
11 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY REGION 103
11.1 MIDDLE EAST AND AFRICA 104
11.1.1 SOUTH AFRICA 111
11.1.2 ISRAEL 114
11.1.3 SAUDI ARABIA 117
11.1.4 U.A.E 120
11.1.5 EGYPT 123
11.1.6 REST OF MIDDLE EAST AND AFRICA 126
12 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 127
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 127
13 SWOT ANALYSIS 128
14 COMPANY PROFILES 129
14.1 ILLUMINA, INC. 129
14.1.1 COMPANY SNAPSHOT 129
14.1.2 REVENUE ANALYSIS 129
14.1.3 COMPANY SHARE ANALYSIS 130
14.1.4 PRODUCT PORTFOLIO 130
14.1.5 RECENT DEVELOPMENTS 130
14.2 DASSAULT SYSTEMES 131
14.2.1 COMPANY SNAPSHOT 131
14.2.2 REVENUE ANALYSIS 131
14.2.3 COMPANY SHARE ANALYSIS 132
14.2.4 PRODUCT PORTFOLIO 132
14.2.5 RECENT DEVELOPMENT 132
14.3 EUROFINS SCIENTIFIC 133
14.3.1 COMPANY SNAPSHOT 133
14.3.2 REVENUE ANALYSIS 133
14.3.3 COMPANY SHARE ANALYSIS 134
14.3.4 PRODUCT PORTFOLIO 134
14.3.5 RECENT DEVELOPMENTS 134
14.4 THERMO FISHER SCIENTIFIC INC. 135
14.4.1 COMPANY SNAPSHOT 135
14.4.2 REVENUE ANALYSIS 135
14.4.3 COMPANY SHARE ANALYSIS 136
14.4.4 PRODUCT PORTFOLIO 136
14.4.5 RECENT DEVELOPMENTS 136
14.5 QIAGEN 137
14.5.1 COMPANY SNAPSHOT 137
14.5.2 COMPANY SHARE ANALYSIS 137
14.5.3 PRODUCT PORTFOLIO 137
14.5.4 RECENT DEVELOPMENTS 137
14.6 SOPHIA GENETICS 138
14.6.1 COMPANY SNAPSHOT 138
14.6.2 PRODUCT PORTFOLIO 138
14.6.3 RECENT DEVELOPMENT 138
14.7 ARDIGEN 139
14.7.1 COMPANY SNAPSHOT 139
14.7.2 PRODUCT PORTFOLIO 139
14.7.3 RECENT DEVELOPMENTS 139
14.8 BIOMAX INFORMATICS AG 140
14.8.1 COMPANY SNAPSHOT 140
14.8.2 PRODUCT PORTFOLIO 140
14.8.3 RECENT DEVELOPMENT 140
14.9 CELBRIDGESCIENCE. 141
14.9.1 COMPANY SNAPSHOT 141
14.9.2 PRODUCT PORTFOLIO 141
14.9.3 RECENT DEVELOPMENTS 141
14.10 DNASTAR 142
14.10.1 COMPANY SNAPSHOT 142
14.10.2 PRODUCT PORTFOLIO 142
14.10.3 RECENT DEVELOPMENTS 142
14.11 ELUCIDATA 143
14.11.1 COMPANY SNAPSHOT 143
14.11.2 PRODUCT PORTFOLIO 143
14.11.3 RECENT DEVELOPMENTS 143
14.12 FIOS GENOMICS 144
14.12.1 COMPANY SNAPSHOT 144
14.12.2 PRODUCT PORTFOLIO 144
14.12.3 RECENT DEVELOPMENTS 144
14.13 INDX. AI. 145
14.13.1 COMPANY SNAPSHOT 145
14.13.2 PRODUCT PORTFOLIO 145
14.13.3 RECENT DEVELOPMENTS 145
14.14 INSILICO MEDICINE 146
14.14.1 COMPANY SNAPSHOT 146
14.14.2 PRODUCT PORTFOLIO 146
14.14.3 RECENT DEVELOPMENTS 146
14.15 JADBIO & GNOSIS DATA ANALYSIS 148
14.15.1 COMPANY SNAPSHOT 148
14.15.2 PRODUCT PORTFOLIO 148
14.15.3 RECENT DEVELOPMENTS 148
14.16 NEOGENOMICS LABORATORIES 150
14.16.1 COMPANY SNAPSHOT 150
14.16.2 REVENUE ANALYSIS 150
14.16.3 PRODUCT PORTFOLIO 151
14.16.4 RECENT DEVELOPMENTS 151
14.17 PAIGE AI, INC. 152
14.17.1 COMPANY SNAPSHOT 152
14.17.2 PRODUCT PORTFOLIO 152
14.17.3 RECENT DEVELOPMENTS 152
14.18 SOMALOGIC OPERATING CO., INC. 153
14.18.1 COMPANY SNAPSHOT 153
14.18.2 PRODUCT PORTFOLIO 153
14.18.3 RECENT DEVELOPMENTS 153
14.19 SOURCE BIOSCIENCE. 154
14.19.1 COMPANY SNAPSHOT 154
14.19.2 PRODUCT PORTFOLIO 154
14.19.3 RECENT DEVELOPMENTS 154
14.20 STRAND LIFE SCIENCES 155
14.20.1 COMPANY SNAPSHOT 155
14.20.2 PRODUCT PORTFOLIO 155
14.20.3 RECENT DEVELOPMENTS 155
15 QUESTIONNAIRE 156
16 RELATED REPORTS 159